Skip to content
PoliticalRepoPoliticalRepo

United States · Law · S

S. 331 (119th)

HALT Fentanyl Act

enactedUnited States· United States Congress· EN

Introduced

30 January 2025

Last action

16 July 2025 · President

Status

Became Public Law No: 119-26.

Sponsors

Sen. Cassidy, Bill [R-LA], Sen. Heinrich, Martin [D-NM], Sen. Grassley, Chuck [R-IA], Sen. Marshall, Roger [R-KS], Sen. Young, Todd [R-IN], Sen. Daines, Steve [R-MT], Sen. Rounds, Mike [R-SD], Sen. Capito, Shelley Moore [R-WV], Sen. Schmitt, Eric [R-MO], Sen. Kennedy, John [R-LA], Sen. Gallego, Ruben [D-AZ], Sen. Hassan, Margaret Wood [D-NH], Sen. Cortez Masto, Catherine [D-NV], Sen. Shaheen, Jeanne [D-NH], Sen. King, Angus S., Jr. [I-ME], Sen. Kelly, Mark [D-AZ], Sen. Cornyn, John [R-TX], Sen. Hawley, Josh [R-MO], Sen. Tillis, Thomas [R-NC], Sen. Graham, Lindsey [R-SC], Sen. Cruz, Ted [R-TX], Sen. Britt, Katie Boyd [R-AL], Sen. Blackburn, Marsha [R-TN], Sen. Lee, Mike [R-UT], Sen. Moody, Ashley [R-FL], Sen. McCormick, David [R-PA], Sen. Collins, Susan M. [R-ME], Sen. Sullivan, Dan [R-AK], Sen. Justice, James C. [R-WV], Sen. Ricketts, Pete [R-NE], Sen. Ernst, Joni [R-IA], Sen. Hyde-Smith, Cindy [R-MS]

Subjects

Discovery layer

Source updated

10 August 2026

Summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the bill establishes a new, alternative registration process for certain schedule I research. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 30 January 2025

    Introduced

    Read twice and referred to the Committee on the Judiciary.

    Source: IntroReferral

  2. 30 January 2025

    Introduced

    Introduced in Senate

    Source: IntroReferral

  3. 27 February 2025

    Reported

    Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Source: Committee

  4. 3 March 2025

    Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.

    Source: Calendars

  5. 3 March 2025

    Reported

    Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.

    Source: Committee

  6. 3 March 2025

    Reported

    Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.

    Source: Committee

  7. 4 March 2025

    Floor

    Motion to proceed to consideration of measure made in Senate. (CR S1488)

    Source: Floor

  8. 5 March 2025

    Floor

    Motion to proceed to measure considered in Senate. (CR S1521)

    Source: Floor

  9. 6 March 2025

    Floor

    Motion to proceed to measure considered in Senate. (CR S1596)

    Source: Floor

  10. 10 March 2025

    Floor

    Motion to proceed to measure considered in Senate. (CR S1623)

    Source: Floor

  11. 11 March 2025

    Floor

    Considered by Senate. (consideration: CR S1659)

    Source: Floor

  12. 13 March 2025

    Vote

    Cloture on the measure invoked in Senate by Yea-Nay Vote. 84 - 15. Record Vote Number: 124. (CR S1735)

    Source: Floor

  13. 14 March 2025

    Floor

    Considered by Senate. (consideration: CR S1762-1765)

    Source: Floor

  14. 14 March 2025

    Vote

    Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127.

    Source: Floor

  15. 18 March 2025

    Floor

    Held at the desk.

    Source: Floor

  16. 18 March 2025

    Floor

    Received in the House.

    Source: Floor

  17. 9 June 2025

    Reported

    Rules Committee Resolution H. Res. 489 Reported to House. Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.

    Source: Floor

  18. 10 June 2025

    Passed

    Rule H. Res. 489 passed House.

    Source: Floor

  19. 11 June 2025

    Floor

    Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.

    Source: Floor

  20. 11 June 2025

    Floor

    The previous question was ordered pursuant to the rule.

    Source: Floor

  21. 11 June 2025

    Floor

    Considered under the provisions of rule H. Res. 489. (consideration: CR H2625-2633)

    Source: Floor

  22. 12 June 2025

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  23. 12 June 2025

    Vote

    On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627)

    Source: Floor

  24. 12 June 2025

    Vote

    Passed/agreed to in House: On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627)

    Source: Floor

  25. 12 June 2025

    Floor

    Considered as unfinished business. (consideration: CR H2806)

    Source: Floor

  26. 8 July 2025

    Floor

    Presented to President.

    Source: Floor

  27. 8 July 2025

    President

    Presented to President.

    Source: President

  28. 16 July 2025

    Became law

    Became Public Law No: 119-26.

    Source: President

  29. 16 July 2025

    Became law

    Signed by President.

    Source: BecameLaw

  30. 16 July 2025

    President

    Signed by President.

    Source: President

Votes

12 June 2025 · passed · On Passage · Passed · Official source

Yes 321 · No 104 · Abstain — · Absent/not voting 7

Showing the first 4 recorded positions. Vote totals above are complete.

14 March 2025 · Bill Passed · On Passage of the Bill S. 331 · Bill Passed · Official source

Yes 84 · No 16 · Abstain — · Absent/not voting 0

Showing the first 4 recorded positions. Vote totals above are complete.

13 March 2025 · Cloture Motion Agreed to · On the Cloture Motion S. 331 · Cloture Motion Agreed to · Official source

Yes 84 · No 15 · Abstain — · Absent/not voting 1

Showing the first 4 recorded positions. Vote totals above are complete.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

7 official files

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Enrolled Bill

    Enrolled Bill · EN

    ViewDownloadOpen at official source

  • Public Law

    summary · EN · 17 July 2025

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Public Law

    Public Law · EN · 16 July 2025

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in Senate

    Engrossed in Senate · EN · 14 March 2025

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported to Senate

    Reported to Senate · EN · 3 March 2025

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    Introduced in Senate · EN · 30 January 2025

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 30 January 2025

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Showing 9 of 37 related records.

Related across the Repo ecosystem

Direct relationships are identifier-backed. Topic context means shared TopicMembership — not a citation and not causation.

Direct relationships

  • Identifier matchPROJECTS_FROM

    Same us record 119-s-331 projected from PoliticalRepo US row.

    HALT Fentanyl Act

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.